AlisonMChurchMD

PubMed

• 10 citations
  A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD
  Tara Renae Rheault, Sanjeev Khindri, Mitra Vahdati-Bolouri, Alison Church, William A. Fahy> ;ERJ Open Research. 2016 Apr 1
• 50 citations
  Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials
  James F. Donohue, Dave Singh, Clara Munzu, Sally Kilbride, Alison Church> ;Respiratory Medicine. 2016 Mar 1
• 53 citations
  Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies.
  Thomas Siler, Edward Kerwin, Ana R. Sousa, Alison Donald, Rehan Ali, Alison Church> ;Respiratory Medicine. 2015 Sep 1
• 47 citations
  Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.
  Dave Singh, Sally Worsley, Chang-Qing Zhu, Liz Hardaker, Alison Church> ;BMC Pulmonary Medicine. 2015 Aug 19
• 73 citations
  Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations
  James F. Donohue, Sally Worsley, Chang Qing Zhu, Liz Hardaker, Alison Church> ;Respiratory Medicine. 2015 Jul 1
• 5 citations
  Daily variation in lung function in COPD patients with combined albuterol and ipratropium: Results from a 4-week, randomized, crossover study
  Dave Singh, Chang-Qing Zhu, Sanjay Sharma, Alison Church, Chris Kalberg> ;Pulmonary Pharmacology & Therapeutics. 2015 Apr 1
• 182 citations
  Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pul...
  Marc Decramer, Antonio Anzueto, Edward Kerwin, Thomas Kaelin, Nathalie Richard, Glenn Crater, Maggie Tabberer, Stephanie Harris, Alison Church> ;The Lancet. Respiratory Medicine. 2014 Jun 1
• 29 citations
  Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
  Navin Goyal, Misba Beerahee, Chris Kalberg, Alison Church, Sally Kilbride, Rashmi Mehta> ;Clinical Pharmacokinetics. 2014 Apr 23
• New roles for mast cells in pathogen defense and allergic disease.
  Hofmann, A.M., Abraham, S.N.> ;Discov Med. 2010 Feb
• Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
  Hofmann, A.M., Scurlock, A.M., Jones, S.M., Palmer, K.P., Lokhnygina, Y., Steele, P.H., Kamilaris, J., Burks, A.W.> ;J Allergy Clin Immunol. 2009-08-01
• New roles for mast cells in modulating allergic reactions and immunity against pathogens.
  Hofmann, A. M., Abraham, S. N.> ;Curr Opin Immunol. 2009 Dec 01
• Join now to see all